Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-15 Sale |
2021-06-17 4:06 pm |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
4,635 | $3.05 | $14,137 | 0 (Direct) |
View |
2020-12-02 Purchase |
2020-12-04 6:47 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
6,400 | $4.1581 | $26,612 | 10,660,554 (Indirect Direct) |
View |
2020-11-13 Purchase |
2020-11-17 7:02 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
977 | $4.2089 | $4,112 | 10,647,754 (Indirect Direct) |
View |
2020-11-10 Purchase |
2020-11-12 6:23 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
2,400 | $3.58 | $8,592 | 10,645,800 (Indirect Direct) |
View |
2020-11-02 Purchase |
2020-11-04 8:12 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
3,100 | $3.56 | $11,036 | 10,641,000 (Indirect Direct) |
View |
2020-09-23 Purchase |
2020-09-25 4:57 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
2,000 | $4.07 | $8,140 | 10,634,800 (Indirect Direct) |
View |
2020-09-18 Purchase |
2020-09-22 5:49 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
3,300 | $4.1348 | $13,645 | 10,630,800 (Indirect Direct) |
View |
2020-09-16 Purchase |
2020-09-17 6:08 pm |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
530 | $3 | $1,590 | 4,635 (Direct) |
View |
2020-09-16 Purchase |
2020-09-16 8:43 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
100 | $3.75 | $375 | 25,924,200 (Indirect Direct) |
View |
2020-08-18 Purchase |
2020-08-20 6:58 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
9,998 | $3.125 | $31,244 | 10,624,000 (Indirect Direct) |
View |
2020-08-19 Purchase |
2020-08-20 4:18 pm |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
4,105 | $3 | $12,315 | 4,105 (Direct) |
View |
2020-07-17 Purchase |
2020-07-21 5:27 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
4,500 | $3 | $13,500 | 10,604,004 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-15 Other |
2021-06-22 08:33 am |
N/A 2024-11-12 |
ReShape Weightloss Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
17,980,277 | $0 | 5,330,277 (Direct) |
View |
2020-09-14 Other |
2020-09-16 8:43 pm |
2020-09-14 2025-09-14 |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
1,200,000 | $0 | 25,924,200 (Direct) |
View |